The Cholinergic Anti-inflammatory Pathway: A Missing Link in Neuroimmunomodulation

Molecular Medicine

Volumn 9, Issue 5-8, 2003, Pages 125-134

  Pavlov, Valentin A ^a   Wang, Hong ^a   Czura, Christopher J ^a   Friedman, Steven G ^a,b   Tracey, Kevin J ^a  

^a North Shore LIJ Research Institute ^*  (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ADRENALIN; ADRENERGIC RECEPTOR; ALPHA INTERMEDIN; ANTIINFLAMMATORY AGENT; BRAIN RECEPTOR; CATECHOLAMINE; CHOLINERGIC RECEPTOR STIMULATING AGENT; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; DOPAMINE; ENDOTOXIN; ESTROGEN; GLUCOCORTICOID; HORMONE; HUMORAL ANTIBODY; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; MUSCARINIC RECEPTOR; NEUROPEPTIDE Y; NEUROTRANSMITTER; NICOTINIC RECEPTOR; NORADRENALIN; PROSTAGLANDIN; PROTEIN SUBUNIT; SEMAPIMOD; TUMOR NECROSIS FACTOR;

ANTERIOR HYPOTHALAMUS; ANTIINFLAMMATORY ACTIVITY; BLOOD BRAIN BARRIER; BRAIN; BRAIN INJURY; CARTILAGE DEGENERATION; CHOLINERGIC SYSTEM; CLINICAL TRIAL; CYTOKINE PRODUCTION; DEGENERATIVE DISEASE; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; EFFERENT NERVE; ENDOCRINE SYSTEM; EPILEPSY; HOST; HOST RESISTANCE; HUMAN; HYPOTENSION; IMMUNE RESPONSE; IMMUNE STATUS; IMMUNE SYSTEM; IMMUNOMODULATION; INFLAMMATION; MACROPHAGE; MODULATION; NERVE FUNCTION; NERVE TRACT; NERVOUS SYSTEM; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; OSTEOPOROSIS; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; RHEUMATOID ARTHRITIS; SEPSIS; SIGNAL TRANSDUCTION; SPINAL CORD; VAGOTOMY; VAGUS NERVE; VAGUS NERVE STIMULATION;

EID: 0142178155     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03402177     Document Type: Review

References (120)

1. Sell S. (2001) Immunology, immunopathology, and immunity (6th ed). ASM Press, Washington, D.C.
2. Baumann H, Gauldie J. (1994) The acute phase response. Immunol. Today 15:74-80.
3. Koj A. (1997) Initiation of acute phase response and synthesis of cytokines. Biochim. Biophys. Acta. 1317:84-94.
4. Tracey KJ et al. (1986) Shock and tissues injury induced by recombinant human cachectin. Science 234:470-4.
5. Wang H et al. (1999) HMG-1 as a lote mediator of endotoxin lethality in mice. Science 285:248-51.
6. Wang H, Yang H, Czura CJ, Sama AE, Tracey KJ. (2001) HMGB1 as a late mediator of lethal systemic inflammation. Am. J. Respir. Crit. Care Med. 164:1768-73.
7. Sporn MB. (1997) The importance of context in cytokine action. Kidney Int. 51:1352-4.
8. Kushner I. (1998) Semantics, inflammation, cytokines and common sense. Cytokine Growth Factor Rev. 9:191-6.
9. Reichlin S. (1993) Neuroendocrine-immune interactions. New Engl. J. Med. 329:1246-53.
10. Peristein RS, Whitnall MH, Abrams JS, Mougey EH, Neta R. (1993) Synergistic roles of interleukin-6, interleukin-1 and tumor necrosis factor in adrenocorticotropin response to bacterial lipopolysaccharide in vivo. Endocrinology 132:946-52.
11. Gaillard RC. (1995) Neuroendocrine-immune system interactions. Trends Endocrinol. Metab. 7:303-9.
12. Mulla A, Buchingham JC. (1999) Regulation of the hypothalamo-pituitary- adrenal axis by cytokines. Baillieres Best. Prac. Res. Clin. Endocriol. Metab. 13:503-21.
13. Rivest S. (2001) How circulating cytokines trigger the neural circuits that control the hypothalamic-pituitary-adrenal axis. Psychoneuroendocrinology 26:761-88.
14. Webster JI, Tonelli L, Sternberg EM. (2002) Neuroendocrine regulation of immunity. Annu. Rev. Immunol. 20:125-63.
15. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. (2000) The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 52:595-638.
16. Borovikova LV et al. (2000) Vogus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405:458-61.
17. Tracey KJ, Czura CJ, Ivanova S. (2001) Mind over immunity. FASEB J. 15:1575-6.
18. Tracey KJ. (2002) The inflammatory reflex. Nature 420:853-9.
19. Blalock JE. (2002) Harnessing a neural-immune circuit to control inflammation and shock. J. Exp. Med. 195:F25-8.
20. Watkins LR, Maier SF, Goehler LE. (1995) Cytokine-to-brain communication: a review and analysis of alternative mechanisms. Life Sci. 57:1011-26.
21. Elmquist JK, Scammell TE, Saper CB. (1997) Mechanisms of CNS response to systemic immune challenge: the febrile response. Trends Neurosci. 20:565-9.
22. Goehler LE, Gaykema RPA, Hansen MK, Anderson K, Maier SF, Watkins L. (2000) Vagal immune-to-brain communication: a visceral chemosensory pathway. Auton. Neurosci. 85:49-59.
23. Goehler LE et al. (1999) Interleukin-1 in immune cells of the abdominal vagus nerve: a link between the immune and nervous system? J. Neurosci. 19:2799-806.
24. Berthhoud HR, Neuhuber WL. (2000) Functional anatomy of afferent vagal system. Auton. Neurosci. 85:1-17.
25. Iversen S, Iversen L, Saper CB. (2000) The autonomic nervous system and the hypothalamus. In: Principles in Neural Science. 4th ed. Kendel ER, Schwartz JH, Jessel TM (eds.) McGraw Hill, New York, pp. 960-81.
26. Gaykema RPA, Dijkstra I, Tilders FJH. (1995) Subdiaphragmic vagotomy suppresses endotoxin-induced activation of hypothalamic corticotropin-releasing hormones neurons and ACTH secretion. Endocrinology 136:4717-20.
27. Ishizuka Y et al. (1997) Effects of area postrema lesion and abdominal vagotomy on interleukin-1β-induced norepinephrine release in the hypothalamic paraventricular nucleus region in the rat. Neurosci. Lett. 223:57-60.
28. Hermann GE, Emch GS, Tovar CA, Rogers RC. (2001) C-Fos generation in the dorsal vagal complex after systemic endotoxin is not dependent on the vagus nerve. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 280:R289-99.
29. Van Dam AM et al. (2000) Vagotomy does not inhibit high dose LPS-indiced interleukin-1β immunoreactivity in the rat brain and pituitary gland. Neurosci. Lett. 285:169-72.
30. Hansen MK et al. (2000) Effects of vagotomy on serum endotoxin, cytokines and corticosterone after intraperitoneal lipopolysaccharide. Am. J. Physiol. 278:R331-6.
31. Hopkins SJ, Rothwell N. (1995) Cytokines and nervous system I: expression and recognition. Trends Neurosci. 18:83-8.
32. Szelényi J. (2001) Cytokines and the central nervous system. Brain Res. Bull. 54:329-459.
33. Rivest S et al. (2000) How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli. Proc. Soc. Exp. Biol. Med. 223:22-38.
34. Banks WA, Kastin AJ, Broadwell RD. (1995) Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation 2:241-8.
35. Nadeau S, Rivest S. (1999) Effects of circulating tumor necrosing factor on the neuronal activity and expression on the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: a view from the blood-brain barrier. Neuroscience 93:1449-64.
36. Ek M, Engblom D, Saha S, Blomqvist A, Jacobsson P-J, Ericsson-Dahlstrand A. (2001) Inflammatory response: pathway across the blood-brain barrier. Nature 410:430-1.
37. Buller KM. (2001) Circumventricular organs: gateways to the brain. Role of circumventricular organs in pro-inflammatory cytokine-induced activation of the hypothalamic-pituitary-adrenal axis. Clin. Experiment. Pharmacol. Physiol. 28:581-9.
38. Afifi AK, Bergmann RA. (1998) Medulla oblongata. In: Functional neuroanatomy. McGraw-Hill, New York, p. 117.
39. Rogers RC, McCann MJ. (1993) Intramedullary connections of the gastric region in the solitary nucleus: a biocytin histochemical tracing study in the rat. J. Auton Nerv. Syst. 42:119-30.
40. Rogers RC, Hermann GE, Travagli RA. (1999) Brainstem pathways responsible for the oesophageal control of gastric motility and tone in the rat. J. Physiol. 514:369-83.
41. Rothwell NJ, Hopkins SL. (1995) Cytokines and the nervous system II: actions and mechanism of action. Trends Neurosci. 18:130-6.
42. Benveniste EN. (1998) Cytokine actions in the central nervous system. Cytokine Growth Factor Rev. 9:259-75.
43. Hallenbeck JM. (2002) The many faces of tumor necrosis factor in stroke. Nature Med. 8:1363-8.
44. Lilly MP, Gann DS. (1992) The hypothalamic-pituitary-adrenal-immune axis: a critical assessment. Arch. Surg. 127:1463-74.
45. McEwen BS et al. (1997) The role of adrenocorticoides as modulators of immune function in health and disease: neural, endocrine and immune interactions. Brain Res. Rev. 23:79-133.
46. Karalis K, Muglia LJ, Bae D, Hildebrand H, Majzoub JA. (1997) CRH and the immune system. J. Immunology 72:131-6.
47. Adcock IM. (2000) Molecular mechanisms of glucocorticoid action. Pulmon. Pharmacol. Ther. 13:115-26.
48. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS. (1995) Role of transcriptional activation of I κB alpha in mediation of immunosuppression by glucocorticoids. Science 270:283-6.
49. McKay LI, Cidlowski JA. (1999) Molecular control of immune/inflammatory responses: interactions between nuclear factor κB and steroid receptor-signaling pathways. Endocrine Rev. 20:435-59.
50. Ghosh S, May MJ, Kopp EB. (1998) NF-κB and Rel proteins: evolutionary conserved mediators of immune responses. Annu. Rev. Immunol. 16:225-60.
51. Hasko G, Szabo C. (1998) Regulation of cytokine and chemokine production by transmitters and co-transmitters of the autonomic nervous system. Biochem. Pharmacol. 56:1079-87.
52. Bellinger DL, Lorton CL, Felton DL. (2001) Innervation of lymphoid organs: association of nerves with cells of the immune system and their implications in disease. In: Psychoneuroimmunology. Ader R, Felten DI, Cohen N (eds.). 3rd ed. Academic Press, New York, pp. 55.
53. van der Poll T, Coyle SM, Barbosa K, Braxton CC, Lowry SF. (1996) Epinephrine inhibits tumor necrosis factor-α and potentiates interleukin-10 production during human endotoxemia. J. Clin. Invest. 97:713-9.
54. Madden KS, Sanders VM, Felten DL. (1995) Catecholamine influences and sympathetic neuronal modulation of immune responsiveness. Annu. Rev. Pharmacol. Toxicol. 35:417-48.
55. 2-adrenoceptors in norepinephrine-induced TNF-α production. Biochim. Biophys. Acta. 1537:49-57.
56. Lipton JM, Catania A. (1997) Anti-inflammatory actions of the neuroimmunomodulator α-MSH. Immunol. Today 140:140-5.
57. Catania A, Airaghi L, Colombo G, Lipton JM. (2000) α-Melonocyte- stimulating hormone in normal human physiology and disease states. Trends Exp. Med. 11:304-8.
58. Macaluso A et al. (1994) Anti-inflammatory influences of α-MSH molecules: central neurogenic and peripheral action. J. Neurosci. 14:2377-82.
59. Catania A, Suffredini AF, Lipton JM. (1995) Endotoxin causes release of α-melanocyte-stimulating hormone in normal human subjects. Neuroimmunomodulation 2:258-62.
60. Janson L, Holmdohl R. (1998) Estrogen-medioted immunosupression in autoimmune diseases. Inflamm. Res. 47:290-301.
61. Behl C. (2002) Oestrogen as a neuroprotective hormone. Nature Rev. Neurosci. 3:433-42.
62. Da Silva JA, Colville-Nash P, Spector TD, Scott DL, Willoughby DA. (1993) Inflammation-induced cartilage degradation in female rodents. Protective role of sex hormones. Arthritis Rhem. 36:1007-15.
63. Deshpande R, Khalili H, Pergolizzi RG, Michael SD, Chang MD. (1997) Estradiol down-regulates LPS-induced cytokine production and NF-κB activation in murine macrophages. Am. J. Reprod. Immunol. 38:46-54.
64. Srivastava S, Weitzmonn MN, Cenci S, Ross FP, Adler S, Pacifici R. (1999) Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and Jun D. J. Clin. Invest. 104:503-13.
65. Strom TB, Deisseroth A, Morganroth J, Carpenter CB, Merrill JP. (1972) Alteration of the cytotoxic action of sensitized lymphocytes by cholinergic agents and activators of adenylate cyclase. Proc. Natl. Acad. Sci. U.S.A. 69:2995-9.
66. Antonica A, Magni F, Mearini L, Paolocci N. (1994) Vagal control of lymphocyte release from rat thymus. J. Auton. Nerv. Syst. 48:187-97.
67. Niijima A, Hori T, Katafuchi T, Ichijo T. (1995) The effect of interleukin-β on the efferent activity of the vagus nerve to the thymus. J. Auton. Nerv. Syst. 54: 137-44.
68. Hori T, Katafuchi T, Take S, Shimizu N, Niijima A. (1995) The autonomic nervous system as a communication channel between the brain and the immune system. Neuroimmunomodulation 2:203-15.
69. Borovikova LV et al. (2000) Role of vagus nerve signaling in CNI-1493-mediated suppression of acute inflammation. Auton. Neurosci. 85:141-7.
70. Caulfield P, Birdsall NJM. (1998) Intl. union of pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol. Reviews 50:279-90.
71. Lindstrom J. (1997) Nicotinic acetylcholine receptors in health and disease. Mol. Neurobiol. 15:193-222.
72. Hiemke C et al. (1996) Expression of alpha subunit genes of nicotinic acetylcholine receptors in human lymphocytes. Neurosci. Lett. 214:171-4.
73. Mita Y, Dobashi K, Suzuki K, Mori M, Nakazawa T. (1996) Induction of muscarinic receptor subtypes in monocytic/macrophagic cells differentiated from EoL-1 cells. Eur. J. Pharmacol. 297:121-7.
74. Toyabe S et al. (1997) Identification o as thymus in mice. Immunol. 92:201-5.
75. Sato KZ et al. (1999) Diversity of mRNA expression for muscarine acetylcholine receptor subtypes and neuronal nicotinic acetylcholine receptor subunits in human mononuclear leukocytes and leukemic cell lines. Neurosci. Lett. 266: 17-20.
76. Walch L, Brink C, Norel X. (2001) The muscarinic receptor subtypes in human blood vessels. Therapie 56:223-6.
77. Tayebati SK, El-Assouad D, Ricci A, Amenta F. (2002) Immunochemical and immunocytochemical characterization of cholinergic markers in human peripheral blood lymphocytes. J. Neuroimmunol. 132:147-55.
78. Kawashima K, Fujii T. (2000) Extraneural cholinergic system in lymphocytes. Pharmacol. Ther. 86:29-48.
79. Tracey KJ et al. (1987) Anti-cachectin/TNF-monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330:662-4.
80. Bernik TR et al. (2002) Pharmacological stimulation of the cholinergic anti-inflammatory pathway. J. Exp. Med. 195:1-9.
81. Villa P et al. (1997) Inhibition of multiple pro-inflammatory mediators (TNF, IL-6, and NO) abrogate lethality in a murine mode of polymicrobial sepsis. J. Endot. Res. 4:197-204.
82. Martiney JA et al. (1998) Prevention and treatment of experimental autoimmune encephalomyelitis by CNI-1493, a macrophage deactivating agent. J. Immunol. 160:5588-95.
83. Akerlund K et al. (1999) Anti-inflammatory effect of a new TNFα inhibitor (CNI-1493) in collagen-induced arthritis in rats. J. Clin. Exp. Immunol. 115:32-41.
84. Bianchi M et al. (1996) Suppression of pro-inflammatory cytokines in monocytes by tetravalent guanylhidrazone. J. Exp. Med. 83:927-36.
85. Wang H, Zhang M, Bianchi M, Sherry B, Sama A, Tracey KJ. (1998) Fetuin (α-2-HS-Glycoprotein) opsonizes cationic macrophage-deactivating molecules. Proc. Natl. Acad. Sci. U.S.A. 95:14429-34.
86. Tracey KJ. (1998) Suppression of TNF and other pro-inflammatory cytokines by tetravalent guanylhydrazone CNI-1492. Prog. Clin. Biol. Res. 397:335-43.
87. Meistrell ME III et al. (1997) TNF is a brain-damaging cytokine in cerebral ischemia. Shock 8:341-8.
88. Hoover DB, Hancock JC, DePorter TE. (1985) Effect of vagotomy on cholinergic parameters in nuclei of rat medulla oblongata. Brain Res. Bull. 15:5-11.
89. Hyde TM, Gibbs M, Peroutka SJ. (1988) Distribution of muscarinic cholinergic receptors in the dorsal vagal complex and other selected nuclei in the human medulla. Brain Res. 447:287-92.
90. Lawrence AJ, Jarrot B. (1996) Neurochemical modulation of cardiovascular control in the nucleus tractus solitarius. Prog. Neurobiol. 48:21-53.
91. Shihara M, Hori N, Hirooka Y, Eshima K, Akaike N, Takeshita A. (1999) Cholinergic system in the nucleus of the solitary tract of rats. Amer. J. Physiol.-Regulat. Integrat. Compar. Physiol. 276:R1141-8.
92. Sykes RM, Spyer KM, Izzo PN. (1997) Demonstration of glutamate immunoreactivity in vagal sensory afferents in the nucleus tractus solitarius of the rat. Brain Res. 762:1-11.
93. Mascarucci P, Perego C, Terrazzino S, De Simoni MG. (1998) Glutamate release in the nucleus tractus solitarius induced by peripheral lipopolysaccharide and interleukin-1β. Neuroscience 86:1285-90.
94. Hornby P. (2001) Receptors and transmission in the brain-gut axis. II. Excitatory amino acid receptors in the brain-gut axis. Am. J. Physiol.-Gastrointest. Liver Physiol. 280:G1055-60.
95. Lin LH, Talman WT. (2000) N-methyl-D-aspartate receptors on neurons that synthesize nitric oxide in rat nucleus tractus solitarii. Neuroscience 100:581-8.
96. Chen C-Y, Bonhom AC. (1998) Non-NMDA and NMDA receptors transmit area postrema input to aortic baroreceptor neurons in NTS. Am. J. Physiol.-Heart Circulat. Physiol. 275:H1695-706.
97. Ferreira M et al. (2001) Evidence for functional alpha-7 neuronal nicotinic receptor subtype located on motoneurones of the dorsol motor nucleus of the vagus. J. Pharmacol. Exper. Therap. 296:260-9.
98. Browning KN, Travagli RA. (2001) Mechanism of action of baclofen in rat dorsal motor nucleus of the vagus. Am. J. Physiol.-Gastrointest. Liver Physiol. 280: G1106-13.
99. Lewis MW, Travagli RA. (2001) Effects of substance P on identified neurons of the rat dorsal motor nucleus of the vagus. Am. J. Physiol.-Gastrointestin. Liver Physiol. 281:G164-72.
100. Blondeau C, Clerc N, Baude A. (2002) Neurokinin-1 and neurokinin-3 receptors are expressed in vagal efferent neurons that innervate different parts of the gastro-intestinal tract. Neuroscience 110:339-49.
101. Atkinson L, Batten TF, Deuchars J. (2000) P2X(2) receptor immunoreactivity in the dorsal vagal complex and area postrema of the rat. Neuroscience 99:683-96.
102. Steinlein O. (1998) New functions for nicotine acetylcholine receptors? Behav. Brain Res. 95:31-5.
103. Marubio LM, Changeux J-P. (2000) Nicotinic acetylcholine receptor knockout mice as animal models for studying receptor function. Eur. J. Pharmacol. 393: 113-21.
104. Leonard S, Bertrand D. (2001) Neuronal nicotinic receptors: from structure to function. Nicotine Tob. Res. 3:203-23.
105. Wang H, Yu M, Ochani M, et al. (2003) Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature 421:384-8.
106. Orr-Urtreger A et al. (1997) Mice deficient in the α7 neuronal nicotinic acetylcholine receptor lack α-bungarotoxin binding sites and hippocampal fast nicotinic currents. J. Neurosci. 17:9165-71.
107. Koroch M et al. (2001) Cardiac variability in critically ill adults: Influence of sepsis. Crit. Care Med. 29:1380-5.
108. Winchell RJ, Hoyt DB. (1996) Spectral analysis of heart rate variability in the ICU: a measure of autonomic function. J. Surg. Res. 63:11-6.
109. Chensue SW, Terebuh PD, Remick DG, Scales WE, Kunkel SL. (1991) In vivo biological and immunohistochemical analysis of interleukin-1 α, β and tumor necrosis factor during experimental endotoxemia. Am. J. Pathol. 138:395-402.
110. Honzikova N, Semrad B, Fiser B, Labrova R. (2000) Baroreflex sensitivity determined by spectral method and heart rate voriability, and two-years mortality in patients after myocardial infarction. Physiol. Res. 49:643-50.
111. Meldrum DR. (1998) Tumor necrosis factor in the heart. Am. J. Physiol. 274:R577-95.
112. Torre-Amione G, Kapadia S, Lee J, Bies RD, Lebovitz R, Mann DL. (1995) Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation 92:1487-93.
113. George MS et al. (2000) Vagus nerve stimulation: a new tool for brain research and therapy. Biol. Psychiatry 47:287-95.
114. Valencia I, Holder DL, Helmers SL, Madsen JR, Riviello JJ. (2001) Vagus nerve stimulation in pediatric epilepsy: a review. Pediatr. Neurol. 25:368-76.
115. George MS et al. (2000) Vagus nerve stimulation. A potential therapy for resistant depression? Psychiatr. Clin. North Am. 23:757-83.
116. Handforth A et al. (1998) Vagus nerve stimulation therapy for partial-onset seizures: A randomized active-control trial. Neurology 51:48-55.
117. Krahl SE, Clark KB, Smith DC, Browning RA. (1998) Locus coeroleus lesions suppress the seizure attenuating effects of vagus nerve stimulation. Epilepsia 39:709-14.
118. Naritoku DK, Terry WJ, Helfert RH. (1995) Regional induction of Fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve. Epilepsy Res. 22:53-62.
119. Wang H et al. (2002) Nicotine inhibits the release of HMGB1 through post-transcriptional mechanism. Shock 17(S1):62.
120. Han JL et al. (2003) Cholinergic suppression of cytokine release from human macrophages. Shock 19(S1):22.